Annual CFI
N/A
December 31, 2024
Summary
- PACB annual cash flow from investing activities is not available.
Performance
PACB Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CFI
N/A
December 31, 2024
Summary
- PACB quarterly cash flow from investing activities is not available.
Performance
PACB Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFI
N/A
December 31, 2024
Summary
- PACB TTM cash flow from investing activities is not available.
Performance
PACB TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
PACB Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
PACB Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time |
Pacific Biosciences Of California Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $23.07 M(-70.0%) | -$809.00 K(-100.4%) |
| Jun 2024 | - | $76.84 M(-325.1%) | $218.45 M(+407.8%) |
| Mar 2024 | - | -$34.14 M(-48.7%) | $43.02 M(+834.4%) |
| Dec 2023 | $4.60 M(-96.0%) | -$66.58 M(-127.5%) | $4.60 M(-97.0%) |
| Sep 2023 | - | $242.32 M(-345.8%) | $151.58 M(-511.5%) |
| Jun 2023 | - | -$98.59 M(+35.9%) | -$36.83 M(-2593.8%) |
| Mar 2023 | - | -$72.55 M(-190.2%) | $1.48 M(-98.7%) |
| Dec 2022 | $116.08 M(-117.1%) | $80.40 M(+49.1%) | $116.08 M(+14.4%) |
| Sep 2022 | - | $53.91 M(-189.4%) | $101.43 M(-141.6%) |
| Jun 2022 | - | -$60.28 M(-243.3%) | -$244.12 M(-62.1%) |
| Mar 2022 | - | $42.05 M(-36.0%) | -$644.65 M(-5.0%) |
| Dec 2021 | -$678.53 M(+209.4%) | $65.75 M(-122.5%) | -$678.53 M(-19.5%) |
| Sep 2021 | - | -$291.65 M(-36.7%) | -$842.78 M(+37.1%) |
| Jun 2021 | - | -$460.81 M(-5740.2%) | -$614.77 M(+292.0%) |
| Mar 2021 | - | $8.17 M(-108.3%) | -$156.82 M(-28.5%) |
| Dec 2020 | -$219.32 M(-453.5%) | -$98.50 M(+54.8%) | -$219.32 M(+76.5%) |
| Sep 2020 | - | -$63.64 M(+2126.0%) | -$124.23 M(+203.5%) |
| Jun 2020 | - | -$2.86 M(-94.7%) | -$40.94 M(+35.3%) |
| Mar 2020 | - | -$54.33 M(+1494.1%) | -$30.26 M(-148.8%) |
| Dec 2019 | $62.05 M(-261.5%) | -$3.41 M(-117.3%) | $62.05 M(+3.5%) |
| Sep 2019 | - | $19.66 M(+151.7%) | $59.94 M(+1939.5%) |
| Jun 2019 | - | $7.81 M(-79.4%) | $2.94 M(-59.8%) |
| Mar 2019 | - | $37.98 M(-789.0%) | $7.32 M(-119.0%) |
| Dec 2018 | -$38.41 M(+2380.0%) | -$5.51 M(-85.2%) | -$38.41 M(+72.9%) |
| Sep 2018 | - | -$37.34 M(-406.3%) | -$22.22 M(-211.1%) |
| Jun 2018 | - | $12.19 M(-257.3%) | $20.00 M(-157.5%) |
| Mar 2018 | - | -$7.75 M(-172.6%) | -$34.78 M(+2145.2%) |
| Dec 2017 | -$1.55 M(-89.6%) | $10.68 M(+118.7%) | -$1.55 M(-72.1%) |
| Sep 2017 | - | $4.88 M(-111.5%) | -$5.56 M(-1407.5%) |
| Jun 2017 | - | -$42.59 M(-267.2%) | $425.00 K(-98.7%) |
| Mar 2017 | - | $25.48 M(+281.9%) | $33.86 M(-327.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2016 | -$14.86 M(-272.7%) | $6.67 M(-38.6%) | -$14.86 M(-66.2%) |
| Sep 2016 | - | $10.87 M(-218.6%) | -$43.97 M(+9.2%) |
| Jun 2016 | - | -$9.16 M(-60.6%) | -$40.26 M(+34.5%) |
| Mar 2016 | - | -$23.24 M(+3.6%) | -$29.93 M(-447.8%) |
| Dec 2015 | $8.61 M(-56.0%) | -$22.43 M(-254.0%) | $8.61 M(-70.9%) |
| Sep 2015 | - | $14.57 M(+1145.0%) | $29.53 M(+6.8%) |
| Jun 2015 | - | $1.17 M(-92.4%) | $27.66 M(+3.7%) |
| Mar 2015 | - | $15.30 M(-1113.9%) | $26.66 M(+36.3%) |
| Dec 2014 | $19.56 M(-159.1%) | -$1.51 M(-111.9%) | $19.56 M(-735.4%) |
| Sep 2014 | - | $12.70 M(+6992.7%) | -$3.08 M(-74.4%) |
| Jun 2014 | - | $179.00 K(-97.8%) | -$12.01 M(-37.9%) |
| Mar 2014 | - | $8.20 M(-133.9%) | -$19.34 M(-41.6%) |
| Dec 2013 | -$33.12 M(-153.6%) | -$24.15 M(-741.8%) | -$33.12 M(-242.5%) |
| Sep 2013 | - | $3.76 M(-152.7%) | $23.24 M(-34.3%) |
| Jun 2013 | - | -$7.14 M(+28.0%) | $35.38 M(-18.2%) |
| Mar 2013 | - | -$5.58 M(-117.3%) | $43.23 M(-30.0%) |
| Dec 2012 | $61.79 M(+858.6%) | $32.20 M(+102.5%) | $61.79 M(+36.1%) |
| Sep 2012 | - | $15.90 M(+2139.6%) | $45.39 M(-13.7%) |
| Jun 2012 | - | $710.00 K(-94.5%) | $52.57 M(+6.6%) |
| Mar 2012 | - | $12.98 M(-17.9%) | $49.33 M(+665.3%) |
| Dec 2011 | $6.45 M(-104.7%) | $15.80 M(-31.5%) | $6.45 M(-106.7%) |
| Sep 2011 | - | $23.08 M(-1013.8%) | -$96.87 M(-20.9%) |
| Jun 2011 | - | -$2.53 M(-91.6%) | -$122.46 M(-28.2%) |
| Mar 2011 | - | -$29.91 M(-65.8%) | -$170.47 M(+23.3%) |
| Dec 2010 | -$138.25 M(-843.5%) | -$87.51 M(+3385.1%) | -$138.25 M(+172.5%) |
| Sep 2010 | - | -$2.51 M(-95.0%) | -$50.74 M(+5.2%) |
| Jun 2010 | - | -$50.53 M(-2290.5%) | -$48.23 M(-2190.5%) |
| Mar 2010 | - | $2.31 M | $2.31 M |
| Dec 2009 | $18.59 M(-278.9%) | - | - |
| Dec 2008 | -$10.39 M(-43.3%) | - | - |
| Dec 2007 | -$18.34 M | - | - |
FAQ
- What is the all time high annual CFI for Pacific Biosciences of California?
- What is the all time high quarterly CFI for Pacific Biosciences of California?
- What is the all time high TTM CFI for Pacific Biosciences of California?
What is the all time high annual CFI for Pacific Biosciences of California?
Pacific Biosciences of California all-time high annual cash flow from investing activities is $116.08 M
What is the all time high quarterly CFI for Pacific Biosciences of California?
Pacific Biosciences of California all-time high quarterly cash flow from investing activities is $242.32 M
What is the all time high TTM CFI for Pacific Biosciences of California?
Pacific Biosciences of California all-time high TTM cash flow from investing activities is $218.45 M